Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Other Non-Current Liabilities: 2010-2025

Historic Other Non-Current Liabilities for Cross Country Healthcare (CCRN) over the last 16 years, with Q3 2025 value amounting to $10.3 million.

  • Cross Country Healthcare's Other Non-Current Liabilities fell 762.5% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year decrease of 762.5%. This contributed to the annual value of $10.1 million for FY2024, which is 458.36% down from last year.
  • As of Q3 2025, Cross Country Healthcare's Other Non-Current Liabilities stood at $10.3 million, which was down 762.5% from $10.3 million recorded in Q2 2025.
  • Cross Country Healthcare's 5-year Other Non-Current Liabilities high stood at $18.0 million for Q4 2022, and its period low was $5.5 million during Q1 2021.
  • Its 5-year average for Other Non-Current Liabilities is $11.3 million, with a median of $10.6 million in 2023.
  • In the last 5 years, Cross Country Healthcare's Other Non-Current Liabilities soared by 15365.02% in 2022 and then crashed by 4109.44% in 2023.
  • Over the past 5 years, Cross Country Healthcare's Other Non-Current Liabilities (Quarter) stood at $9.0 million in 2021, then soared by 100.0% to $18.0 million in 2022, then crashed by 41.09% to $10.6 million in 2023, then decreased by 4.58% to $10.1 million in 2024, then increased by 2.26% to $10.3 million in 2025.
  • Its last three reported values are $10.3 million in Q3 2025, $10.3 million for Q2 2025, and $10.2 million during Q1 2025.